Clinical trials data
Verbal Fluency in schizophrenia and psychosis trials: 107 registered studies
Every registered schizophrenia and psychosis study on ClinicalTrials.gov that names Verbal Fluency in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered schizophrenia and psychosis studies name it in an outcome measure
- 107
- Name it in a primary outcome, 32%
- 34 of 107
Tests named in the same studies
- 1
Trail Making Test30 studies, 3 as a primary outcome
- 2
Verbal Learning24 studies, 6 as a primary outcome
- 3
Tower Planning21 studies, 10 as a primary outcome
- 4
Digit Span Test19 studies, 4 as a primary outcome
- 5
Card Sorting Test (Berg)14 studies, 4 as a primary outcome
- 6
Stroop Color-Word Test12 studies, 4 as a primary outcome
- 7
Continuous Performance Test11 studies, 4 as a primary outcome
- 8
Symbol Coding10 studies, 2 as a primary outcome
- 9
Letter-Number Sequencing Task9 studies, 3 as a primary outcome
- 10
Category Fluency8 studies, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 0 |
| 2004 | 2 | 0 |
| 2005 | 2 | 1 |
| 2006 | 0 | 0 |
| 2007 | 6 | 4 |
| 2008 | 1 | 1 |
| 2009 | 3 | 2 |
| 2010 | 3 | 3 |
| 2011 | 3 | 0 |
| 2012 | 2 | 1 |
| 2013 | 4 | 0 |
| 2014 | 5 | 3 |
| 2015 | 5 | 2 |
| 2016 | 6 | 2 |
| 2017 | 5 | 3 |
| 2018 | 7 | 0 |
| 2019 | 7 | 3 |
| 2020 | 2 | 0 |
| 2021 | 6 | 0 |
| 2022 | 6 | 1 |
| 2023 | 6 | 1 |
| 2024 | 7 | 1 |
| 2025 | 5 | 1 |
| 2026 | 11 | 3 |
Phases and study sizes
By phase
- Phase 13 studies, 2 as a primary outcome
- Phase 1/21 studies, 1 as a primary outcome
- Phase 219 studies, 8 as a primary outcome
- Phase 2/32 studies, 0 as a primary outcome
- Phase 33 studies, 1 as a primary outcome
- Phase 412 studies, 4 as a primary outcome
- Not applicable61 studies, 16 as a primary outcome
- Observational6 studies, 2 as a primary outcome
Participants per study
- Phase 274 median, 45 to 177
- Phase 455 median, 40 to 77
- Not applicable62 median, 33 to 129
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 19 | 74 | 45 to 177 |
| Phase 4 | 12 | 55 | 40 to 77 |
| Not applicable | 61 | 62 | 33 to 129 |
When schizophrenia and psychosis trials measure it
Latest time point of each outcome
- Within a day9 outcomes, 3 as a primary outcome
- Up to 4 weeks19 outcomes, 6 as a primary outcome
- 1 to 3 months42 outcomes, 18 as a primary outcome
- 3 to 6 months16 outcomes, 4 as a primary outcome
- 6 to 12 months8 outcomes, 1 as a primary outcome
- 1 to 2 years8 outcomes, 1 as a primary outcome
- Over 2 years1 outcomes, 0 as a primary outcome
- No duration given4 outcomes, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
103 of the 107 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting15 studies, 2 as a primary outcome
- Not yet recruiting7 studies, 2 as a primary outcome
- Active, not recruiting3 studies, 0 as a primary outcome
- Completed61 studies, 25 as a primary outcome
- Stopped early4 studies, 0 as a primary outcome
- Status unknown17 studies, 5 as a primary outcome
What they test
- Behavioral26 studies, 6 as a primary outcome
- Drug44 studies, 19 as a primary outcome
- Device28 studies, 7 as a primary outcome
- Dietary supplement6 studies, 4 as a primary outcome
- Procedure2 studies, 0 as a primary outcome
- Diagnostic test1 studies, 0 as a primary outcome
- Other18 studies, 3 as a primary outcome
- None given3 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States38 studies, 17 as a primary outcome
- Canada11 studies, 1 as a primary outcome
- Spain9 studies, 1 as a primary outcome
- China7 studies, 2 as a primary outcome
- United Kingdom7 studies, 4 as a primary outcome
- France6 studies, 0 as a primary outcome
- Poland6 studies, 2 as a primary outcome
- Denmark5 studies, 1 as a primary outcome
- Germany5 studies, 0 as a primary outcome
- Taiwan5 studies, 2 as a primary outcome
- Ukraine4 studies, 0 as a primary outcome
- Bulgaria3 studies, 0 as a primary outcome
34 countries in all. A study with sites in several counts in each; 7 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed schizophrenia and psychosis studies that name Verbal Fluency: 43 of 61, 70%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed schizophrenia and psychosis studies that name Verbal Fluency | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 9, 15% | 776, 10% |
| Results on ClinicalTrials.gov only | 23, 38% | 1,139, 14% |
| A results paper only | 11, 18% | 1,711, 22% |
| Neither | 18, 30% | 4,327, 54% |
The 107 studies
107 studies match. 34 name Verbal Fluency in a primary outcome. Median size 62 participants. Median time to the primary outcome: 9 weeks.
Loading 107 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 0 |
| 2004 | 2 | 0 |
| 2005 | 2 | 1 |
| 2006 | 0 | 0 |
| 2007 | 6 | 4 |
| 2008 | 1 | 1 |
| 2009 | 3 | 2 |
| 2010 | 3 | 3 |
| 2011 | 3 | 0 |
| 2012 | 2 | 1 |
| 2013 | 4 | 0 |
| 2014 | 5 | 3 |
| 2015 | 5 | 2 |
| 2016 | 6 | 2 |
| 2017 | 5 | 3 |
| 2018 | 7 | 0 |
| 2019 | 7 | 3 |
| 2020 | 2 | 0 |
| 2021 | 6 | 0 |
| 2022 | 6 | 1 |
| 2023 | 6 | 1 |
| 2024 | 7 | 1 |
| 2025 | 5 | 1 |
| 2026 | 11 | 3 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 18, other 89. Interventional 101, observational 6.
As a primary outcomeSecondary or other outcomeVerbal Fluency
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07856381 | Start2026 | PhaseObservational | ConditionsSchizophrenia and psychosis, Healthy volunteers | Participants180 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07853079 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants88 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07748078 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Substance use and addiction | Participants140 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07747181 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants135 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07745140 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants66 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07680959 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07658898 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants74 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07616999 | Start2026 | PhaseObservational | ConditionsSchizophrenia and psychosis | Participants178 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07506070 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder, Autism, Anxiety, PTSD and OCD | Participants160 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07446569 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants294 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07428460 | Start2026 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants75 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07427485 | Start2025 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants40 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07404085 | Start2025 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder | Participants160 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07371325 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Obesity and diabetes | Participants36 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07245212 | Start2025 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Substance use and addiction | Participants80 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07184619 | Start2026 | PhasePhase 3 | ConditionsSchizophrenia and psychosis | Participants400 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07173465 | Start2023 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants45 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07119268 | Start2025 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Sleep and sleep disorders | Participants115 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06542640 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Healthy volunteers | Participants300 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06529029 | Start2024 | PhasePhase 2/3 | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder | Participants30 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06464848 | Start2025 | PhaseObservational | ConditionsSchizophrenia and psychosis | Participants48 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06423651 | Start2022 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants160 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06251193 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis | Participants49 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06226779 | Start2024 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Aging, frailty and exercise | Participants63 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06038955 | Start2022 | PhaseNot applicable | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder | Participants62 | Lead sponsorOther | StatusCompleted | Library tests named
|
Questions, answered from the data
How many schizophrenia and psychosis trials use Verbal Fluency?
107 registered schizophrenia and psychosis studies on ClinicalTrials.gov name it in an outcome measure, 34 of them in a primary outcome: 17% of the condition's 640 studies with a cognitive outcome, against 11% of all of them. It is the 2nd most named test in schizophrenia and psychosis trials.
Which tests do schizophrenia and psychosis trials use with Verbal Fluency?
The Trail Making Test (30 studies), Verbal Learning (24 studies) and Tower Planning (21 studies).
How many participants do phase 2 schizophrenia and psychosis trials that use Verbal Fluency enroll?
Half of the phase 2 studies that name it enroll 74 participants or fewer, and the middle half enroll 45 to 177. 19 of them give a size.
When do schizophrenia and psychosis trials measure Verbal Fluency?
Half of the primary outcomes that name Verbal Fluency are measured within 9 weeks of the start, and the middle half from 4 weeks to 12 weeks. 33 primary outcomes give a duration.
How many completed schizophrenia and psychosis trials that use Verbal Fluency have reported results?
43 of the 61 completed studies that name it, 70%, have reported results: 32 posted them on ClinicalTrials.gov, 20 have a results paper linked to the registry record, and 9 did both. The other 18 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run Verbal Fluency in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.